Study: Cannabis May Reduce Body Weight, Improve Insulin Sensitivity

A new study published in the Canadian Journal of Physiology and Pharmacologycannamissouri has found that cannabis may provide a treatment option for obesity by reducing body weight and improving insulin sensitivity.

“Cannabinoid 1 (CB1) receptor antagonists [such as cannabis] reduce body weight and improve insulin sensitivity”, according to the study. “Preclinical data indicates that an acute dose of CB1 antagonist rimonabant causes an increase in blood glucose. Exendin-4 [another CB1 antagonist] improves glucose-stimulated insulin secretion in pancreas, and reduces appetite through activation of GLP-1 receptors in the central nervous system and liver.”

Read moreStudy: Cannabis May Reduce Body Weight, Improve Insulin Sensitivity